Abbott Brings Rapid Testing to the Front Lines

Mddionline, 31/03/2020

Partagé par : 

Beesens Teams

Abbott Brings Rapid Testing to the Front Lines

"Abbott’s new ID NOW COVID-19 test, which earned emergency use authorization (EUA) from FDA last week, was highlighted during President Donald Trump’s COVID-19 taskforce press briefing on March 30. FDA Commissioner Stephen Hahn spoke about the rapid approval of Abbott’s point-of-care test for COVID-19. “Normally these tests take months to develop,” Hahn noted during the briefing. “I was on the phone today with the Abbott CEO who told me this..." Lire la suite